Session Summary
The use of i2b2 for determining feasibility of clinical studies and clinical trials, focusing on the use of i2b2 in networks across the country, and novel approaches to allowing investigators to perform feasibility studies using i2b2-based client tools.
Presenters (4)
Jack London, PhD
Research Professor Cancer Biology
Thomas Jefferson University
Director, Informatics Shared Resource
Sidney Kimmel Cancer Center
Douglas MacFadden
Chief Informatics Officer
Harvard Catalyst
Kavi Wagholikar, PhD
Assistant in Computer Science
Massachusetts General Hospital
Instructor
Harvard Medical School
Nich Wattanasin, MS
Corporate Team Lead
Partners HealthCare
Presentations (4)
Presentation 1: SHRINE Update
Presenter(s): Doug MacFadden
- Brief overview of SHRINE
- New SHRINE Data Steward Application
- New SHRINE Dashboard
- Graphing and Reporting
- Future Plans
Presentation 2: Feasibility Studies Using SHRINE and i2b2
Presenter(s): Nich Wattanasin
New features added to SHRINE and i2b2 Web Clients to help improve the workflow of identifying and extracting patient sets for clinical studies or trials.
New SHRINE Features:
- Zoom Query Status
- Graph Results
- Print Query Report
- Download Results
- Flagging Query
New i2b2 Features:
- Extract Patient Sets from SHRINE
- Patient Set Downloader
- Manage Data Files
- CSV Data File
Presentation 3: Using i2b2 Data to Determine Clinical Trial Feasibility in the TriNetX Network
Presenter(s): Jack London
- Overview of cancer clinical trial accrual problem
- TriNetX Clinical Research Network and Jefferson University's participation
Presentation 4: SMART on FHIR on i2b2
Presenter(s): Kavi Wagholikar
- New FHIR Cell
- i2b2-quickstart
- Standardizing docker containers
